Randomized double-blind clinical trial comparing clobetasol and dexamethasone for the topical treatment of symptomatic oral chronic graft-versus-host disease.

[1]  H. Greinix,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease , 2015 .

[2]  Daniel Wolff,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  Â. Maiolino,et al.  Early and late oral features of chronic graft-versus-host disease , 2014, Revista brasileira de hematologia e hemoterapia.

[4]  H. Gwak,et al.  Comparison of budesonide and dexamethasone for local treatment of oral chronic graft-versus-host disease. , 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[5]  B. Storer,et al.  Clinical benefit of response in chronic graft-versus-host disease. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  Qianming Chen,et al.  Amlexanox is as effective as dexamethasone in topical treatment of erosive oral lichen planus: a short-term pilot study. , 2012, Oral surgery, oral medicine, oral pathology and oral radiology.

[7]  G. Lodi,et al.  Pharmacokinetics study about topical clobetasol on oral mucosa. , 2012, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[8]  M. Levitt,et al.  Improvement in oral chronic graft-versus-host disease with the administration of effervescent tablets of topical budesonide-an open, randomized, multicenter study. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  Â. Maiolino,et al.  Oral involvement of chronic graft-versus-host disease in hematopoietic stem cell transplant recipients. , 2011, General dentistry.

[10]  G. Koshy,et al.  Whole saliva physico-biochemical changes and quality of life in head and neck cancer patients following conventional radiation therapy: a prospective longitudinal study. , 2011, Indian journal of cancer.

[11]  F. Falaki,et al.  A comparative pilot study of low intensity laser versus topical corticosteroids in the treatment of erosive-atrophic oral lichen planus. , 2011, Photomedicine and laser surgery.

[12]  D. Kleiner,et al.  Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  K. Stevenson,et al.  Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GVHD , 2010, Bone Marrow Transplantation.

[14]  E. Miranda,et al.  Taste disorders and oral evaluation in patients undergoing allogeneic hematopoietic SCT , 2010, Bone Marrow Transplantation.

[15]  K. Alavi,et al.  Efficacy of topical phenytoin on chemotherapy-induced oral mucositis; a pilot study , 2010, Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences.

[16]  M. Carrozzo,et al.  Topical clobetasol in the treatment of atrophic-erosive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations. , 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[17]  D. Migliari,et al.  Double-blind, crossover, placebo-controlled clinical trial with clobetasol propionate in desquamative gingivitis. , 2009, Brazilian dental journal.

[18]  I. Alevizos,et al.  Oral graft-versus-host disease. , 2008, Oral diseases.

[19]  L. Sreebny,et al.  Unstimulated whole saliva flow rate in relation to sicca symptoms in Hungary. , 2008, Oral diseases.

[20]  J. Simon,et al.  Oral graft‐versus‐host disease: successful therapy with extracorporeal photopheresis and topical tacrolimus , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[21]  I. Kocyiğit,et al.  The effect of budesonide mouthwash on oral chronic graft versus host disease , 2007, American journal of hematology.

[22]  A. Borkhardt,et al.  Oral graft vs. host disease in children – Treatment with topical tacrolimus ointment , 2007, Pediatric transplantation.

[23]  J. Fricain,et al.  Long‐term efficacy of topical tacrolimus on oral lesions of chronic graft‐versus‐host disease , 2007, The British journal of dermatology.

[24]  M. L. Barjas-Castro,et al.  Oral involvement in chronic graft versus host disease: a prospective study of 19 Brazilian patients. , 2007, General dentistry.

[25]  L. Gerber,et al.  Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[26]  G. Burmester,et al.  Potencies of topical glucocorticoids to mediate genomic and nongenomic effects on human peripheral blood mononuclear cells. , 2006, Biochemical pharmacology.

[27]  R. Schwartz,et al.  Adverse effects of topical glucocorticosteroids. , 2006, Journal of the American Academy of Dermatology.

[28]  P. Lachenbruch,et al.  Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[29]  K. Liu,et al.  Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation , 2005, Bone Marrow Transplantation.

[30]  M. Turner,et al.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[31]  A. Eckardt,et al.  Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus. , 2004, Oral oncology.

[32]  E. Farmer,et al.  Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft‐vs.‐host disease , 2004, Photodermatology, photoimmunology & photomedicine.

[33]  M. Gonzalez-Moles,et al.  Treatment of severe erosive gingival lesions by topical application of clobetasol propionate in custom trays. , 2003, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[34]  S. Elad,et al.  Budesonide: a novel treatment for oral chronic graft versus host disease. , 2003, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[35]  A. Pertovaara,et al.  Thermal sensation and pain in oral lichen planus and lichenoid reaction. , 2003, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[36]  F. Locatelli,et al.  Response to mycophenolate mofetil therapy in refractory chronic graft-versus-host disease. , 2003, Haematologica.

[37]  M. Nucci,et al.  Relationship between salivary flow rates and Candida counts in subjects with xerostomia. , 2002, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[38]  J. Ship,et al.  Development of a Visual Analogue Scale questionnaire for subjective assessment of salivary dysfunction. , 2001, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[39]  J. Epstein,et al.  Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases. , 2001, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[40]  J. Epstein,et al.  Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease , 2000, Bone Marrow Transplantation.

[41]  A. Shojaei.  Buccal mucosa as a route for systemic drug delivery: a review. , 1998, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.